XFOR logo

X4 Pharmaceuticals (XFOR) Working Capital

Annual Working Capital

$99.21 M
-$7.14 M-6.71%

December 31, 2023


Summary


Performance

XFOR Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Quarterly Working Capital

$113.71 M
-$32.80 M-22.39%

September 30, 2024


Summary


Performance

XFOR Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

XFOR Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.7%-22.4%
3 y3 years+39.0%-22.4%
5 y5 years+234.3%+60.3%

XFOR Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.7%+34.3%-22.4%+271.8%
5 y5-year-17.2%+39.0%-22.4%+271.8%
alltimeall time-17.2%+1663.9%-22.4%+1892.5%

X4 Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2024
-
$113.71 M(-22.4%)
Jun 2024
-
$146.51 M(+129.7%)
Mar 2024
-
$63.79 M(-35.7%)
Dec 2023
$99.21 M(-6.7%)
$99.21 M(-19.0%)
Sep 2023
-
$122.44 M(-2.4%)
Jun 2023
-
$125.40 M(+59.3%)
Mar 2023
-
$78.74 M(-26.0%)
Dec 2022
$106.35 M(+44.0%)
$106.35 M(+86.6%)
Sep 2022
-
$57.01 M(+86.4%)
Jun 2022
-
$30.58 M(-45.3%)
Mar 2022
-
$55.91 M(-24.3%)
Dec 2021
$73.86 M(+3.5%)
$73.86 M(+9.5%)
Sep 2021
-
$67.47 M(-23.5%)
Jun 2021
-
$88.25 M(-16.2%)
Mar 2021
-
$105.29 M(+47.5%)
DateAnnualQuarterly
Dec 2020
$71.36 M(-40.5%)
$71.36 M(-11.6%)
Sep 2020
-
$80.73 M(-18.5%)
Jun 2020
-
$99.11 M(-13.1%)
Mar 2020
-
$114.00 M(-4.9%)
Dec 2019
$119.83 M(+303.7%)
$119.83 M(+68.9%)
Sep 2019
-
$70.94 M(-15.0%)
Jun 2019
-
$83.44 M(+753.8%)
Mar 2019
-
$9.77 M(-67.1%)
Dec 2018
$29.68 M(-56.9%)
$29.68 M(-17.7%)
Sep 2018
-
$36.08 M(-22.2%)
Jun 2018
-
$46.35 M(-21.7%)
Mar 2018
-
$59.23 M(-14.0%)
Dec 2017
$68.85 M(-1185.3%)
$68.85 M(+244.0%)
Sep 2017
-
$20.01 M(-415.5%)
Dec 2016
-$6.34 M(-471.0%)
-$6.34 M
Dec 2015
$1.71 M
-

FAQ

  • What is X4 Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals annual working capital year-on-year change?
  • What is X4 Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals quarterly working capital year-on-year change?

What is X4 Pharmaceuticals annual working capital?

The current annual working capital of XFOR is $99.21 M

What is the all time high annual working capital for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high annual working capital is $119.83 M

What is X4 Pharmaceuticals annual working capital year-on-year change?

Over the past year, XFOR annual working capital has changed by -$7.14 M (-6.71%)

What is X4 Pharmaceuticals quarterly working capital?

The current quarterly working capital of XFOR is $113.71 M

What is the all time high quarterly working capital for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high quarterly working capital is $146.51 M

What is X4 Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, XFOR quarterly working capital has changed by -$32.80 M (-22.39%)